Wiseman RW - Search Results

1

Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer.

Lancaster JM, Brownlee HA, Bell DA, Futreal PA, Marks JR, Berchuck A, Wiseman RW, Taylor JA. Lancaster JM, et al. Among authors: wiseman rw. Mol Carcinog. 1996 Nov;17(3):160-2. doi: 10.1002/(SICI)1098-2744(199611)17:3<160::AID-MC8>3.0.CO;2-J. Mol Carcinog. 1996. PMID: 8944076

2

Dideoxy fingerprinting assay for BRCA1 mutation analysis.

Lancaster JM, Berchuck A, Futreal PA, Wiseman RW. Lancaster JM, et al. Among authors: wiseman rw. Mol Carcinog. 1997 Jul;19(3):176-9. Mol Carcinog. 1997. PMID: 9254884

3

Dinucleotide repeat polymorphism in the THRA1 gene.

Futreal PA, Barrett JC, Wiseman RW. Futreal PA, et al. Among authors: wiseman rw. Hum Mol Genet. 1992 Apr;1(1):66. doi: 10.1093/hmg/1.1.66-a. Hum Mol Genet. 1992. PMID: 1301142 No abstract available.

4

An Alu polymorphism intragenic to the TP53 gene.

Futreal PA, Barrett JC, Wiseman RW. Futreal PA, et al. Among authors: wiseman rw. Nucleic Acids Res. 1991 Dec 25;19(24):6977. doi: 10.1093/nar/19.24.6977. Nucleic Acids Res. 1991. PMID: 1762941 Free PMC article.

5

Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.

Futreal PA, Cochran C, Marks JR, Iglehart JD, Zimmerman W, Barrett JC, Wiseman RW. Futreal PA, et al. Among authors: wiseman rw. Cancer Res. 1994 Apr 1;54(7):1791-4. Cancer Res. 1994. PMID: 7511052

6

An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene.

Lancaster JM, Wiseman RW, Berchuck A. Lancaster JM, et al. Among authors: wiseman rw. Obstet Gynecol. 1996 Feb;87(2):306-9. doi: 10.1016/0029-7844(95)00405-X. Obstet Gynecol. 1996. PMID: 8559544

7

Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11.

Bennett LM, Haugen-Strano A, Cochran C, Brownlee HA, Fiedorek FT Jr, Wiseman RW. Bennett LM, et al. Among authors: wiseman rw. Genomics. 1995 Oct 10;29(3):576-81. doi: 10.1006/geno.1995.9963. Genomics. 1995. PMID: 8575748

8

Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test.

Lancaster JM, Cochran CJ, Brownlee HA, Evans AC, Berchuck A, Futreal PA, Wiseman RW. Lancaster JM, et al. Among authors: wiseman rw. J Natl Cancer Inst. 1996 Apr 17;88(8):552-4. doi: 10.1093/jnci/88.8.552. J Natl Cancer Inst. 1996. PMID: 8606385 No abstract available.

9

BRCA2 mutations in primary breast and ovarian cancers.

Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA. Lancaster JM, et al. Among authors: wiseman rw. Nat Genet. 1996 Jun;13(2):238-40. doi: 10.1038/ng0696-238. Nat Genet. 1996. PMID: 8640235

10

Recent advances in the molecular genetics of hereditary breast and ovarian cancer.

Lancaster JM, Wiseman RW. Lancaster JM, et al. Among authors: wiseman rw. Prog Clin Biol Res. 1997;396:31-51. Prog Clin Biol Res. 1997. PMID: 9108588 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters